Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2011 Mar-Apr;17(2):105-9.
doi: 10.4103/1319-3767.77238.

Variceal band ligation in the prevention of variceal bleeding: a multicenter trial

Asma Ouakaa-Kchaou  1 , Jamel Kharrat, Khaoula Mir, Boussourra Houda, Nabil Abdelli, Salem Ajmi, Msaddek Azzouz, Hatem Ben Abdallah, Nabyl Ben Mami, Slim Bouzaidi, Sofiene Chouaib, Lamia Golli, Wissem Melki, Taoufik Najjar, Hammouda Saffar, Najet Belhadj, Abdeljabbar Ghorbel
Affiliations
Multicenter Study

Variceal band ligation in the prevention of variceal bleeding: a multicenter trial

Asma Ouakaa-Kchaou et al. Saudi J Gastroenterol. 2011 Mar-Apr.

Abstract

Background/aim: Variceal bleeding is a life-threatening complication of portal hypertension with a high probability of recurrence. Treatment to prevent first bleeding or rebleeding is mandatory. The study has been aimed at investigating the effectiveness of endoscopic band ligation in preventing upper gastrointestinal bleeding in patients with portal hypertension and to establish the clinical outcome of patients.

Patients and methods: We analyzed in a multicenter trial, the efficacy and side effects of endoscopic band ligation for the primary and secondary prophylaxis of esophageal variceal bleeding. We assigned 603 patients with portal hypertension who were hospitalized to receive treatment with endoscopic ligation. Sessions of ligation were repeated every two to three weeks until the varices were eradicated. The primary end point was recurrent bleeding.

Results: The median follow-up period was 32 months. A total of 126 patients had recurrent bleeding. All episodes were related to portal hypertension and 79 to recurrent variceal bleeding. There were major complications in 51 patients (30 had bleeding esophageal ulcers). Seventy-eight patients died, 26 deaths were related to variceal bleeding and 1 to bleeding esophageal ulcers.

Conclusions: A great improvement in the prevention of variceal bleeding has emerged over the last years. However, further therapeutic options that combine higher efficacy, better tolerance and fewer side effects are needed.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Comment in

References

    1. Garcia-Pagan JC, De Gottardi A, Bosch J. Review article: The modern management of portal hypertension – primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Aliment Pharmacol Ther. 2008;28:178–86. - PubMed
    1. Baron TH, Wong Kee Song LM. Endoscopic variceal band ligation. Am J Gastroenterol. 2009;104:1083–5. - PubMed
    1. Attwell AR, Chen YK. Endoscopic ligation in the treatment of variceal bleeding. Tech Gastrointest Endosc. 2005;7:18–25.
    1. Villanueva C, Piqueras M, Aracil C, Gomez C, Lopez-Balaguer JM, Gonzalez B, et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol. 2006;45:560–7. - PubMed
    1. Dell’Era A, Sotela JC, Fabris FM, Petazzi G, Reati R, Iannuzzi F, et al. Primary prophylaxis of variceal bleeding in cirrhotic patients: A cohort study. Dig Liv Dis. 2008;40:936–43. - PubMed

Publication types

MeSH terms